CrossRef Pathogenesis, prevention, and therapeutic advances in hepatitis B, C, and D Junjie Liu, Tong Yuan, Lin Xue, Huifang Liang Virology Journal .2025;[Epub] CrossRef Small nucleic acid drugs-the dawn of functional cure of chronic hepatitis B Lu Zhang, Yu Cao, Sijing Zhuang, Jingjing Sun, Qiao Tong, Jianjun Xi, Shourong Liu, Rangxiao Zhuang Frontiers in Pharmacology .2025;[Epub] CrossRef Hepatitis B functional cure: Current and future perspective Sudheer Marrapu, Jinit R Soni, Kislaya Kamal, Ramesh Kumar World Journal of Hepatology .2025;[Epub] CrossRef Strategies to Achieve Functional Cure in HBV: Focus on siRNA Eyyel Karthikeyan, Robert G
The decision to initiate GLP-1 therapy should always be based on primary indicationstype 2 diabetes management or weight management in obesitywith lipid improvements considered a valuable secondary benefit
GLP-1 Increases Kiss-1 mRNA Expression in Kisspeptin-Expressing Neuronal Cell
Previous work reports that the GLP-1R agonist, exendin-4, stimulates cell proliferation in juvenile but not adult human islets (73)
Their complementary roles may enhance the bodys ability to manage oxidative stress and support overall cellular health
A drinkable vial provides natural source for weight loss
